Drugs / BAY1067197
BAY1067197
also known as
Neladenoson bialanate · Bialanate de neladenoson · Bialanato de neladenoson · Neladenoson dalanate
Small molecule targets ADORA1 via activation
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT04320771 | Nov 2017 → Aug 2018 | — | Bayer | Terminated | No outcome recorded |
| Phase 1 | NCT04322253 | Aug 2017 → Aug 2018 | — | Bayer | Terminated | No outcome recorded |
| Phase 23 trials · 2 missed | ||||||
| Phase 2 | NCT03098979 | May 2017 → May 2018 | heart failure | Bayer | Completed | Missed primary |
| Phase 2 | NCT02992288 | Feb 2017 → Mar 2018 | heart failure | Bayer | Completed | Missed primary |
| Phase 2 | NCT01945606 | Nov 2013 → Sep 2014 | heart failure | Bayer | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02040233 Comparator | Jan 2014 → Jan 2015 | heart failure | Bayer | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY1067197 | “Neladenoson bialanate (BAY 1067197)” NCT04320771 ↗5“Neladenoson bialanate (BAY 1067197)” NCT04322253 ↗ “Neladenoson bialanate (BAY1067197)” NCT02992288 ↗ “Neladenoson bialanate (BAY1067197)” NCT03098979 ↗ |
| Known as | Bialanate de neladenoson | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314392 ↗ |
| Known as | Bialanato de neladenoson | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314392 ↗ |
| Known as | Neladenoson bialanate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04322253 ↗ |
| Known as | Neladenoson dalanate | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314392 ↗ |
| Action | Activate | “Adenosine A1 receptor agonist” CHEMBL5314392 ↗1“partial A1 agonist BAY1067197” NCT01945606 ↗ |
| Modality | Small molecule | — CHEMBL5314392 ↗ |
| Route | Oral | “Oral administration of a single dose of 30 mg (3×10 mg Tablet) BAY1067197” NCT01945606 ↗ |
| Target | ADORA1 | “Adenosine A1 receptor agonist” CHEMBL5314392 ↗ |